Medicaid redeterminations; Fiscal Responsibility Act; Improving Seniors' Timely Access to Care Act; Prior Authorization issues; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Connect Act
Improving Seniors' Timely Access to Care Act; Prior Authorization issues; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Connect Act
Fiscal Responsibility Act; Further Additional Continuing Appropriations and Other Extensions Act, 2024 (Public Law 118-35); Further Consolidated Appropriations Act, 2024 (H.R. 2882)
Duration: August 1, 2008
to
present
General Issues: Medicare/Medicaid , Health Issues , Insurance , Budget/Appropriations
Spending: about $1,870,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for Highmark Wholecare (formerly Gateway Health Plan, LP.) , earning $30,000. The report was filed on April 22.
Original Filing: 301570109.xml
Lobbying Issues
Medicaid redeterminations; Fiscal Responsibility Act; Improving Seniors' Timely Access to Care Act; Prior Authorization issues; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Connect Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Medicaid redeterminations; Fiscal Responsibility Act; Improving Seniors' Timely Access to Care Act; Prior Authorization issues; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Connect Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Improving Seniors' Timely Access to Care Act; Prior Authorization issues; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Connect Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Fiscal Responsibility Act; Further Additional Continuing Appropriations and Other Extensions Act, 2024 (Public Law 118-35); Further Consolidated Appropriations Act, 2024 (H.R. 2882)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2023
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for Highmark Wholecare (formerly Gateway Health Plan, LP.) , earning $30,000. The report was filed on Jan. 22.
Original Filing: 301535351.xml
Lobbying Issues
Medicaid redeterminations; Fiscal Responsibility Act; Improving Seniors' Timely Access to Care Act; Prior Authorization issues; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Connect Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Medicaid redeterminations; Fiscal Responsibility Act; Improving Seniors' Timely Access to Care Act; Prior Authorization issues; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Connect Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Improving Seniors' Timely Access to Care Act; Prior Authorization issues; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Connect Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Fiscal Responsibility Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for Highmark Wholecare (formerly Gateway Health Plan, LP.) , earning $30,000. The report was filed on Oct. 20, 2023.
Original Filing: 301515770.xml
Lobbying Issues
Medicaid redeterminations; Fiscal Responsibility Act; Improving Seniors' Timely Access to Care Act; Prior Authorization issues; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Connect Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Medicaid redeterminations; Fiscal Responsibility Act; Improving Seniors' Timely Access to Care Act; Prior Authorization issues; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Connect Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Improving Seniors' Timely Access to Care Act; Prior Authorization issues; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Connect Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Fiscal Responsibility Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2023
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for Highmark Wholecare (formerly Gateway Health Plan, LP.) , earning $30,000. The report was filed on July 19, 2023.
Original Filing: 301481928.xml
Lobbying Issues
Medicaid redeterminations; Fiscal Responsibility Act; Improving Seniors' Timely Access to Care Act; Prior Authorization issues; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Connect Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Medicaid redeterminations; Fiscal Responsibility Act; Improving Seniors' Timely Access to Care Act; Prior Authorization issues; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Connect Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Improving Seniors' Timely Access to Care Act; Prior Authorization issues; Medicare advantage; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4201-F); Connect Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Fiscal Responsibility Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2023
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for Highmark Wholecare (formerly Gateway Health Plan, LP.) , earning $30,000. The report was filed on April 21, 2023.
Original Filing: 301468287.xml
Lobbying Issues
Pharmacy Benefit Manager Transparency Act, S. 127; Improving Seniors Timely Access to Care Act; Public Health Emergency (PHE); Medicare Advantage payment issues, 2024 Advance Notice (2/1/23) from CMS
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Pharmacy Benefit Manager Transparency Act, S. 127; Improving Seniors Timely Access to Care Act; Public Health Emergency (PHE); Medicare Advantage payment issues, 2024 Advance Notice (2/1/23) from CMS
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Medicare Advantage payment issues, 2024 Advance Notice (2/1/23) from CMS; Improving Seniors Timely Access to Care Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2023
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on April 20, 2023.
Original Filing: 301467391.xml
Lobbying Issues
Pharmacy Benefit Manager Transparency Act, S. 127; Improving Seniors Timely Access to Care Act; Public Health Emergency (PHE); Medicare Advantage payment issues, 2024 Advance Notice (2/1/23) from CMS
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Pharmacy Benefit Manager Transparency Act, S. 127; Improving Seniors Timely Access to Care Act; Public Health Emergency (PHE); Medicare Advantage payment issues, 2024 Advance Notice (2/1/23) from CMS
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Medicare Advantage payment issues, 2024 Advance Notice (2/1/23) from CMS; Improving Seniors Timely Access to Care Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Jan. 20, 2023.
Original Filing: 301438666.xml
Lobbying Issues
Implementation of HR 1319, American Rescue Plan Act of 2021; HR 943, Social Determinants for Moms Act; FMAP issues; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act; Protecting Medicare and American Farmers from Sequester Cuts Act PL 117-71; PA Medicaid MCO contract requirements; Medicare Advantage; Inflation Reduction Act, healthcare provisions; Improving Seniors Timely Access to Care Act of 2021 H.R. 3173; Consolidated Appropriations Act, 2023 (P.L. 117-328)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (H.R. 1319); HR 943, Social Determinants for Moms Act; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act; The Connect for Health Act (H.R. 2903/S.1512); PA Medicaid MCO contract requirements; Medicare Advantage; Inflation Reduction Act, healthcare provisions; Improving Seniors Timely Access to Care Act of 2021 H.R. 3173; Consolidated Appropriations Act, 2023 (P.L. 117-328)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (H.R. 1319); Build Back Better reconciliation package; PA Medicaid MCO contract requirements; Medicare Advantage; Inflation Reduction Act, healthcare provisions; Improving Seniors Timely Access to Care Act of 2021 H.R. 3173; Consolidated Appropriations Act, 2023 (P.L. 117-328)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Extending Government Funding and Delivering Emergency Assistance Act (H.R. 5305); Build Back Better reconciliation package; FY 2022 Labor-HHS Appropriations bill; Infrastructure Investment and Jobs Act (H.R. 3684); Protecting Medicare and American Farmers from Sequester Cuts Act PL 117-71; Inflation Reduction Act, healthcare provisions; Consolidated Appropriations Act, 2023 (P.L. 117-328)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2022
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Oct. 20, 2022.
Original Filing: 301419946.xml
Lobbying Issues
Implementation of HR 1319, American Rescue Plan Act of 2021; HR 943, Social Determinants for Moms Act; FMAP issues; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act; Protecting Medicare and American Farmers from Sequester Cuts Act PL 117-71; PA Medicaid MCO contract requirements; Medicare Advantage; Inflation Reduction Act, healthcare provisions; Improving Seniors Timely Access to Care Act of 2021 H.R. 3173
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (H.R. 1319); HR 943, Social Determinants for Moms Act; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act; The Connect for Health Act (H.R. 2903/S.1512); PA Medicaid MCO contract requirements; Medicare Advantage; Inflation Reduction Act, healthcare provisions; Improving Seniors Timely Access to Care Act of 2021 H.R. 3173
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (H.R. 1319); Build Back Better reconciliation package; PA Medicaid MCO contract requirements; Medicare Advantage; Inflation Reduction Act, healthcare provisions; Improving Seniors Timely Access to Care Act of 2021 H.R. 3173
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Extending Government Funding and Delivering Emergency Assistance Act (H.R. 5305); Build Back Better reconciliation package; FY 2022 Labor-HHS Appropriations bill; Infrastructure Investment and Jobs Act (H.R. 3684); Protecting Medicare and American Farmers from Sequester Cuts Act PL 117-71; Inflation Reduction Act, healthcare provisions
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2022
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on July 20, 2022.
Original Filing: 301390198.xml
Lobbying Issues
Implementation of HR 1319, American Rescue Plan Act of 2021; HR 943, Social Determinants for Moms Act; FMAP issues; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act; Protecting Medicare and American Farmers from Sequester Cuts Act PL 117-71; PA Medicaid MCO contract requirements; Medicare Advantage; Budget Reconciliation Package
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (H.R. 1319); HR 943, Social Determinants for Moms Act; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act; The Connect for Health Act (H.R. 2903/S.1512); PA Medicaid MCO contract requirements; Medicare Advantage; Budget Reconciliation Package
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (H.R. 1319); Build Back Better reconciliation package; PA Medicaid MCO contract requirements; Medicare Advantage
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Extending Government Funding and Delivering Emergency Assistance Act (H.R. 5305); Build Back Better reconciliation package; FY 2022 Labor-HHS Appropriations bill; Infrastructure Investment and Jobs Act (H.R. 3684); Protecting Medicare and American Farmers from Sequester Cuts Act PL 117-71; Budget Reconciliation Package
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2022
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on April 19, 2022.
Original Filing: 301360527.xml
Lobbying Issues
Implementation of HR 1319, American Rescue Plan Act of 2021; HR 943, Social Determinants for Moms Act; FMAP issues; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act; Protecting Medicare and American Farmers from Sequester Cuts Act PL 117-71; PA Medicaid MCO contract requirements
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (H.R. 1319); HR 943, Social Determinants for Moms Act; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act; The Connect for Health Act (H.R. 2903/S.1512); PA Medicaid MCO contract requirements
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (H.R. 1319); Build Back Better reconciliation package; PA Medicaid MCO contract requirements
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Extending Government Funding and Delivering Emergency Assistance Act (H.R. 5305); Build Back Better reconciliation package; FY 2022 Labor-HHS Appropriations bill; Infrastructure Investment and Jobs Act (H.R. 3684); Protecting Medicare and American Farmers from Sequester Cuts Act PL 117-71
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2021
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Jan. 20, 2022.
Original Filing: 301337117.xml
Lobbying Issues
Implementation of HR 1319, American Rescue Plan Act of 2021; HR 943, Social Determinants for Moms Act; FMAP issues; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act; Protecting Medicare and American Farmers from Sequester Cuts Act PL 117-71
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (H.R. 1319); HR 943, Social Determinants for Moms Act; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act; The Connect for Health Act (H.R. 2903/S.1512)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (H.R. 1319); Build Back Better reconciliation package
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Extending Government Funding and Delivering Emergency Assistance Act (H.R. 5305); Build Back Better reconciliation package; FY 2022 Labor-HHS Appropriations bill; Infrastructure Investment and Jobs Act (H.R. 3684); Protecting Medicare and American Farmers from Sequester Cuts Act PL 117-71
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2021
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Oct. 19, 2021.
Original Filing: 301303648.xml
Lobbying Issues
Implementation of HR 1319, American Rescue Plan Act of 2021; HR 943, Social Determinants for Moms Act; FMAP issues; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (H.R. 1319); HR 943, Social Determinants for Moms Act; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act; The Connect for Health Act (H.R. 2903/S.1512)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of American Rescue Plan Act of 2021 (H.R. 1319); Build Back Better reconciliation package
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Extending Government Funding and Delivering Emergency Assistance Act (H.R. 5305); Build Back Better reconciliation package; FY 2022 Labor-HHS Appropriations bill; Infrastructure Investment and Jobs Act (H.R. 3684)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2021
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on July 10, 2021.
Original Filing: 301274811.xml
Lobbying Issues
HR 1868, to prevent across-the-board direct spending cuts, and for other purposes; HR 1319, American Rescue Plan Act of 2021; HR 943, Social Determinants for Moms Act; FMAP issues; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
HR 1319, American Rescue Plan Act of 2021; HR 943, Social Determinants for Moms Act; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 1319, American Rescue Plan Act of 2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S. Con Res 5, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
BUCHANAN INGERSOLL & ROONEY PC amended a lobbying report for representation of GATEWAY HEALTH PLAN, LP. in Q12021 on Nov. 20, 2021.
Original Filing: 301318410.xml
Lobbying Issues
HR 1868, to prevent across-the-board direct spending cuts, and for other purposes; HR 1319, American Rescue Plan Act of 2021; HR 943, Social Determinants for Moms Act; FMAP issues; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
HR 1319, American Rescue Plan Act of 2021; HR 943, Social Determinants for Moms Act; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 1319, American Rescue Plan Act of 2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S. Con Res 5, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
BUCHANAN INGERSOLL & ROONEY PC amended a lobbying report for representation of GATEWAY HEALTH PLAN, LP. in Q12021 on May 10, 2021.
Original Filing: 301270836.xml
Lobbying Issues
HR 1868, to prevent across-the-board direct spending cuts, and for other purposes; HR 1319, American Rescue Plan Act of 2021; HR 943, Social Determinants for Moms Act; FMAP issues; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
HR 1319, American Rescue Plan Act of 2021; HR 943, Social Determinants for Moms Act; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 1319, American Rescue Plan Act of 2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S. Con Res 5, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on April 16, 2021.
Original Filing: 301254654.xml
Lobbying Issues
HR 1868, to prevent across-the-board direct spending cuts, and for other purposes; HR 1319, American Rescue Plan Act of 2021; HR 943, Social Determinants for Moms Act; FMAP issues; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
HR 1319, American Rescue Plan Act of 2021; HR 943, Social Determinants for Moms Act; S. 386, Telemedicine Modernization Act; HR 1332, Telemedicine Modernization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 1319, American Rescue Plan Act of 2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S. Con Res 5, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2020
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Jan. 21, 2021.
Original Filing: 301244126.xml
Lobbying Issues
CREATES ACT, PL 116-134; Surprise Billing legislation; Medicaid MCO; Interim Final Rule Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (CMS-1744-IFC) CY 2021 Medicare Advantage/Part D Final Rate Notice. Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139); Consolidated Appropriations Act, 2021 (Including Coronavirus Stimulus & Relief; H.R. 133; P.L. 116-260)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
CREATES ACT, PL 116-134; Surprise Billing legislation; Medicaid MCO; Interim Final Rule Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (CMS-1744-IFC) CY 2021 Medicare Advantage/Part D Final Rate Notice. Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139); Consolidated Appropriations Act, 2021 (Including Coronavirus Stimulus & Relief; H.R. 133; P.L. 116-260)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
CREATES ACT, PL 116-134; Surprise Billing legislation; Medicaid MCO; Interim Final Rule Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (CMS-1744-IFC) CY 2021 Medicare Advantage/Part D Final Rate Notice. Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139); Consolidated Appropriations Act, 2021 (Including Coronavirus Stimulus & Relief; H.R. 133; P.L. 116-260)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2020
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Oct. 19, 2020.
Original Filing: 301213729.xml
Lobbying Issues
CREATES ACT, PL 116-134; Surprise Billing legislation; Medicaid MCO; Interim Final Rule Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (CMS-1744-IFC) CY 2021 Medicare Advantage/Part D Final Rate Notice. Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
CREATES ACT, PL 116-134; Surprise Billing legislation; Medicaid MCO; Interim Final Rule Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (CMS-1744-IFC) CY 2021 Medicare Advantage/Part D Final Rate Notice. Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2020
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on July 19, 2020.
Original Filing: 301193481.xml
Lobbying Issues
CREATES ACT, PL 116-134; Surprise Billing legislation; Medicaid MCO; Interim Final Rule Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (CMS-1744-IFC) CY 2021 Medicare Advantage/Part D Final Rate Notice. Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
CREATES ACT, PL 116-134; Surprise Billing legislation; Medicaid MCO; Interim Final Rule Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (CMS-1744-IFC) CY 2021 Medicare Advantage/Part D Final Rate Notice. Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2020
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on April 20, 2020.
Original Filing: 301173507.xml
Lobbying Issues
Advancing Care for Exceptional Kids Act (HR 3325) (HR 1226/S317); Social determinants of health; Rx Drug Pricing; ACA reform efforts; CREATES ACT; 1332 Waivers Application Process; Social Determinants of Health Accelerator Act, HR 4004; Surprise Billing legislation; Medicaid MCO; Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); H.R. 6379
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Advancing Care for Exceptional Kids Act (HR 3325) (HR 1226/S317); Social determinants of health; Rx Drug Pricing; ACA reform efforts; CREATES ACT; 1332 Waivers Application Process; Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); H.R. 6379
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Advancing Care for Exceptional Kids Act (HR 3325) (HR 1226/S317); Social determinants of health; Rx Drug Pricing; ACA reform efforts; CREATES ACT; 1332 Waivers Application Process; Surprise Billing legislation; Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); Families First Coronvirus Reponse Act (P.L. 116-127); Coronvirus Preparedness and Response Supplemental Appropriations Act (P.L. 116-123); H.R. 6379
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2019
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Jan. 21, 2020.
Original Filing: 301124400.xml
Lobbying Issues
Advancing Care for Exceptional Kids Act (HR 3325) (HR 1226/S317); Social determinants of health; Rx Drug Pricing; ACA reform efforts; CREATES ACT; 1332 Waivers Application Process; Social Determinants of Health Accelerator Act, HR 4004; Surprise Billing legislation; Medicaid MCO
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Advancing Care for Exceptional Kids Act (HR 3325) (HR 1226/S317); Social determinants of health; Rx Drug Pricing; ACA reform efforts; CREATES ACT; 1332 Waivers Application Process;
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Advancing Care for Exceptional Kids Act (HR 3325) (HR 1226/S317); Social determinants of health; Rx Drug Pricing; ACA reform efforts; CREATES ACT; 1332 Waivers Application Process; Surprise Billing legislation
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2019
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Oct. 21, 2019.
Original Filing: 301076370.xml
Lobbying Issues
Advancing Care for Exceptional Kids Act (HR 3325) (HR 1226/S317); Social determinants of health; Rx Drug Pricing; ACA reform efforts; CREATES ACT; 1332 Waivers Application Process; Social Determinants of Health Accelerator Act, HR 4004; Surprise Billing legislation; Medicaid MCO
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Advancing Care for Exceptional Kids Act (HR 3325) (HR 1226/S317); Social determinants of health; Rx Drug Pricing; ACA reform efforts; CREATES ACT; 1332 Waivers Application Process
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Advancing Care for Exceptional Kids Act (HR 3325) (HR 1226/S317); Social determinants of health; Rx Drug Pricing; ACA reform efforts; CREATES ACT; 1332 Waivers Application Process; Surprise Billing legislation
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2019
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on July 22, 2019.
Original Filing: 301054979.xml
Lobbying Issues
Advancing Care for Exceptional Kids Act (HR 3325) (HR 1226/S317); Social determinants of health; Rx Drug Pricing; ACA reform efforts; CREATES ACT; 1332 Waivers Application Process
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Advancing Care for Exceptional Kids Act (HR 3325) (HR 1226/S317); Social determinants of health; Rx Drug Pricing; ACA reform efforts; CREATES ACT; 1332 Waivers Application Process
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2019
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on April 22, 2019.
Original Filing: 301035098.xml
Lobbying Issues
Advancing Care for Exceptional Kids Act (HR 3325) (HR 1226/S317); Social determinants of health; Rx Drug Pricing; ACA reform efforts
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2018
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Jan. 17, 2019.
Original Filing: 301006933.xml
Lobbying Issues
SNP Reauthorization Act of 2017 (HR 3168); Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (S.870)
MMI provisions of Medicare proposed rule; Further Continuing and Security Assistance Appropriations Act (HR 2028); HR 6, SUPPORT for Patients and Communities Act; Advancing Care for Exceptional Kids Act (HR 3325)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Further Continuing and Security Assistance Appropriations Act (HR 2028)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Health care reform; Further Continuing and Security Assistance Appropriations Act (HR 2028)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2018
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Oct. 22, 2018.
Original Filing: 300994498.xml
Lobbying Issues
SNP Reauthorization Act of 2017 (HR 3168); Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (S.870)
MMI provisions of Medicare proposed rule; Further Continuing and Security Assistance Appropriations Act (HR 2028); Medicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and 2019 draft Call Letter; HR 6, SUPPORT for Patients and Communities Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Further Continuing and Security Assistance Appropriations Act (HR 2028)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Health care reform; Further Continuing and Security Assistance Appropriations Act (HR 2028)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2018
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on July 19, 2018.
Original Filing: 300969145.xml
Lobbying Issues
SNP Reauthorization Act of 2017 (HR 3168); Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (S.870)
MMI provisions of Medicare proposed rule; Further Continuing and Security Assistance Appropriations Act (HR 2028); Medicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and 2019 draft Call Letter; HR 6, SUPPORT for Patients and Communities Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Further Continuing and Security Assistance Appropriations Act (HR 2028)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Health care reform; Further Continuing and Security Assistance Appropriations Act (HR 2028)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2018
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on April 20, 2018.
Original Filing: 300952127.xml
Lobbying Issues
SNP Reauthorization Act of 2017 (HR 3168); Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (S.870)
MMI provisions of Medicare proposed rule; Further Continuing and Security Assistance Appropriations Act (HR 2028); Medicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and 2019 draft Call Letter
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Further Continuing and Security Assistance Appropriations Act (HR 2028)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Health care reform; Further Continuing and Security Assistance Appropriations Act (HR 2028)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2017
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Jan. 19, 2018.
Original Filing: 300929254.xml
Lobbying Issues
SNP Reauthorization Act of 2017 (HR 3168); Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (S.870)
MMI provisions of Medicare proposed rule; Further Continuing and Security Assistance Appropriations Act (HR 2028); Tax Cuts and Jobs Act (HR 1)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Further Continuing and Security Assistance Appropriations Act (HR 2028); Tax Cuts and Jobs Act (HR 1)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Health care reform; Further Continuing and Security Assistance Appropriations Act (HR 2028); Tax Cuts and Jobs Act (HR 1)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2017
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Oct. 19, 2017.
Original Filing: 300908335.xml
Lobbying Issues
Healthcare reform; American Health Care Act (H.R. 1628); S. Con. Res 3, Budget Reconciliation; Medicare Advantage Call Letter; chronic care; SCHIP reauthorization
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
S. Con. Res 3, Budget Reconciliation
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Healthcare reform; American Health Care Act (H.R. 1628); S. Con. Res 3, Budget Reconciliation
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Healthcare reform; American Health Care Act (H.R. 1628)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2017
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on July 19, 2017.
Original Filing: 300888516.xml
Lobbying Issues
Healthcare reform; American Health Care Act (H.R. 1628); S. Con. Res 3, Budget Reconciliation; Medicare Advantage Call Letter; chronic care
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
S. Con. Res 3, Budget Reconciliation
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Healthcare reform; American Health Care Act (H.R. 1628); S. Con. Res 3, Budget Reconciliation
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Healthcare reform; American Health Care Act (H.R. 1628)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2017
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on April 20, 2017.
Original Filing: 300874826.xml
Lobbying Issues
Healthcare reform; American Health Care Act (H.R. 1628); S. Con. Res 3, Budget Reconciliation; Medicare Advantage Call Letter; chronic care
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
S. Con. Res 3, Budget Reconciliation
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Healthcare reform; American Health Care Act (H.R. 1628); S. Con. Res 3, Budget Reconciliation
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Healthcare reform; American Health Care Act (H.R. 1628)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2016
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Jan. 24, 2017.
Original Filing: 300858538.xml
Lobbying Issues
S. 2104, Preserving Medicare Advantage for all Medicare Beneficiaries Act of 2015; HR 4275, Medicare Advantage Quality Payment Relief Act of 2015; Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter. Advancing Care for Exceptional Kids Act of 2015 (H.R. 546. S. 298); 21st Century Cures Act; FY 2017 Continuing Resolution
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Healthcare Freedom Reconciliation Act of 2015 (H.R. 3762); Protecting Americans from Tax Hikes Act of 2015; Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Specialty drugs' effects on health care premiums.; Chronic Care models of care H.R. 2646, the Helping Families in Mental Health Crisis Act Energy and Commerce; Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter. Advancing Care for Exceptional Kids Act of 2015 (H.R. 546. S. 298).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2016
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Oct. 19, 2016.
Original Filing: 300832898.xml
Lobbying Issues
S. 2104, Preserving Medicare Advantage for all Medicare Beneficiaries Act of 2015; HR 4275, Medicare Advantage Quality Payment Relief Act of 2015; Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter. Advancing Care for Exceptional Kids Act of 2015 (H.R. 546. S. 298).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Healthcare Freedom Reconciliation Act of 2015 (H.R. 3762); Protecting Americans from Tax Hikes Act of 2015; Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Specialty drugs' effects on health care premiums.; Chronic Care models of care H.R. 2646, the Helping Families in Mental Health Crisis Act Energy and Commerce; Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter. Advancing Care for Exceptional Kids Act of 2015 (H.R. 546. S. 298).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2016
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on July 20, 2016.
Original Filing: 300819725.xml
Lobbying Issues
S. 2104, Preserving Medicare Advantage for all Medicare Beneficiaries Act of 2015; HR 4275, Medicare Advantage Quality Payment Relief Act of 2015; Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter. Advancing Care for Exceptional Kids Act of 2015 (H.R. 546. S. 298).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Healthcare Freedom Reconciliation Act of 2015 (H.R. 3762); Protecting Americans from Tax Hikes Act of 2015; Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
specialty drugs' effects on health care premiums.; Chronic Care models of care H.R. 2646, the Helping Families in Mental Health Crisis Act Energy and Commerce; Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter. Advancing Care for Exceptional Kids Act of 2015 (H.R. 546. S. 298).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2016
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on April 20, 2016.
Original Filing: 300797895.xml
Lobbying Issues
S. 2104, Preserving Medicare Advantage for all Medicare Beneficiaries Act of 2015; HR 4275, Medicare Advantage Quality Payment Relief Act of 2015; Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
S. Con Res 11, an original concurrent resolution setting forth the congressional budget for the United State Government for FY 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025. Healthcare Freedom Reconciliation Act of 2015 (H.R. 3762); Protecting Americans from Tax Hikes Act of 2015; Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
specialty drugs' effects on health care premiums.; Chronic Care models of care H.R. 2646, the Helping Families in Mental Health Crisis Act Energy and Commerce; Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2015
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Jan. 20, 2016.
Original Filing: 300779382.xml
Lobbying Issues
S. 2104, Preserving Medicare Advantage for all Medicare Beneficiaries Act of 2015; HR 4275, Medicare Advantage Quality Payment Relief Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
S. Con Res 11, an original concurrent resolution setting forth the congressional budget for the United State Government for FY 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025. Healthcare Freedom Reconciliation Act of 2015 (H.R. 3762); Protecting Americans from Tax Hikes Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
specialty drugs' effects on health care premiums.; Chronic Care models of care H.R. 2646, the Helping Families in Mental Health Crisis Act Energy and Commerce
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2015
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Oct. 20, 2015.
Original Filing: 300759790.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues; Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; new product offerings for Medicare & Medicaid. S. Con Res 11, an original concurrent resolution setting forth the congressional budget for the United State Government for FY 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025. HR 2, Medicare Access and CHIP Reauthorization Act of 2015. Advance Notice of Methodological Changes for Calendar Year (CY) 2016 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2016 Call Letter; an Announcement of CY 2016 Medicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter (80 FR 10749; OR 45 CFR Parts 144, 147, 153, et al.); Chronic Care models of care
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
S. Con Res 11, an original concurrent resolution setting forth the congressional budget for the United State Government for FY 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025. HR 2, Medicare Access and CHIP Reauthorization Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of PL111-148; Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; specialty drugs' effects on health care premiums. S. Con Res 11, an original concurrent resolution setting forth the congressional budget for the United State Government for FY 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025; Chronic Care models of care
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
2nd Quarter, 2015
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on July 20, 2015.
Original Filing: 300741318.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues; Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; new product offerings for Medicare & Medicaid. S. Con Res 11, an original concurrent resolution setting forth the congressional budget for the United State Government for FY 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025. HR 2, Medicare Access and CHIP Reauthorization Act of 2015. Advance Notice of Methodological Changes for Calendar Year (CY) 2016 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2016 Call Letter; an Announcement of CY 2016 Medicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter (80 FR 10749; OR 45 CFR Parts 144, 147, 153, et al.)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
S. Con Res 11, an original concurrent resolution setting forth the congressional budget for the United State Government for FY 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025. HR 2, Medicare Access and CHIP Reauthorization Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of PL111-148; Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; specialty drugs' effects on health care premiums. S. Con Res 11, an original concurrent resolution setting forth the congressional budget for the United State Government for FY 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
1st Quarter, 2015
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on April 20, 2015.
Original Filing: 300722459.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues; Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; new product offerings for Medicare & Medicaid. S. Con Res 11, an original concurrent resolution setting forth the congressional budget for the United State Government for FY 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025. HR 2, Medicare Access and CHIP Reauthorization Act of 2015. Advance Notice of Methodological Changes for Calendar Year (CY) 2016 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2016 Call Letter; an Announcement of CY 2016 Medicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter (80 FR 10749; OR 45 CFR Parts 144, 147, 153, et al.)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
S. Con Res 11, an original concurrent resolution setting forth the congressional budget for the United State Government for FY 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025. HR 2, Medicare Access and CHIP Reauthorization Act of 2015
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of PL111-148; Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; specialty drugs' effects on health care premiums. S. Con Res 11, an original concurrent resolution setting forth the congressional budget for the United State Government for FY 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
4th Quarter, 2014
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Jan. 20, 2015.
Original Filing: 300702166.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues; Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; new product offerings for Medicare & Medicaid
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
HR 83; Consolidated and Further Continuing Appropriations Act, 2015; General issues related to budget
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of PL111-148; Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; specialty drugs' effects on health care premiums
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
3rd Quarter, 2014
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Oct. 15, 2014.
Original Filing: 300676814.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues; 2015 Medicare Advantage (MA) Capitation Rates, Parts C & D Payment Policies & 2015 Call Letter (4.7.14); Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; new product offerings for Medicare & Medicaid
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Proposed FY 2015 Federal Budget by Administration, March 4, 2014; General issues related to budget
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of PL111-148; Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; specialty drugs' effects on health care premiums
Agencies Lobbied
Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2014
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on July 18, 2014.
Original Filing: 300662676.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues; * 2015 Medicare Advantage (MA) Capitation Rates, Parts C & D Payment Policies & 2015 Call Letter (4.7.14); Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
1. Proposed FY 2015 Federal Budget by Administration, March 4, 2014
2. General issues related to budget
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Implementation of PL111-148; Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; specialty drugs' effects on health care premiums.
Agencies Lobbied
Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2014
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on April 16, 2014.
Original Filing: 300637153.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues. * S. 2011, Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014, 101, 103, 401; * HR 4015, SGR Repeal and Medicare Provider Payment Modernization Act of 2014, 2, 4; * HR 4302, Protecting Access to Medicare Act of 2014, 101, 107; * Advance Notice of Methodological Changes for Calendar Year (C4) 2015 for Medicare Advantage (MA) Capitation Rates, Parts C & D Payment Policies & 2015 Call Letter
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
1. Proposed FY 2015 Federal Budget by Administration, March 4, 2014
2. General issues related to budget
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Implementation of PL111-148
Agencies Lobbied
Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2013
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Jan. 16, 2014.
Original Filing: 300620583.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
General federal budget issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
General work w/HHS on federal regulations.
Agencies Lobbied
Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2013
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Oct. 17, 2013.
Original Filing: 300596617.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
General federal budget issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
General work w/HHS on federal regulations.
Agencies Lobbied
Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2013
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on July 18, 2013.
Original Filing: 300582418.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2013
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on April 18, 2013.
Original Filing: 300559460.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2012
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Jan. 22, 2013.
Original Filing: 300539515.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2012
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Oct. 17, 2012.
Original Filing: 300517144.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2012
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on July 16, 2012.
Original Filing: 300494242.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2012
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on April 17, 2012.
Original Filing: 300468057.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2011
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Jan. 17, 2012.
Original Filing: 300450074.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2011
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Oct. 14, 2011.
Original Filing: 300420316.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2011
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on July 19, 2011.
Original Filing: 300396273.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2011
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on April 19, 2011.
Original Filing: 300376340.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2010
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Jan. 12, 2011.
Original Filing: 300346287.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2010
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Oct. 14, 2010.
Original Filing: 300321096.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2010
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on July 15, 2010.
Original Filing: 300297347.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2010
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on April 20, 2010.
Original Filing: 300271455.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2009
In Q4, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Jan. 14, 2010.
Original Filing: 300236305.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Executive Office of the President (EOP)
3rd Quarter, 2009
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Oct. 16, 2009.
Original Filing: 300207407.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2009
In Q2, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on July 20, 2009.
Original Filing: 300189165.xml
Lobbying Issues
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2009
In Q1, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on April 17, 2009.
Original Filing: 300154915.xml
Lobbying Issues
Health care regulatory matters; Medicare advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2008
In Q4, BUCHANAN INGERSOLL & ROONEY lobbied for GATEWAY HEALTH PLAN, LP. , earning $30,000. The report was filed on Jan. 15, 2009.
Original Filing: 300120658.xml
Lobbying Issues
Health care regulatory matters; Medicare advantage; general issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2008
In Q3, BUCHANAN INGERSOLL & ROONEY PC lobbied for GATEWAY HEALTH PLAN, LP. , earning $10,000. The report was filed on Oct. 16, 2008.
Original Filing: 300094934.xml
Lobbying Issues
Health care regulatory matters; Medicare advantage
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Medicare/Medicaid
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate